ASTC
Astrotech Corporation3.9200
+0.4400+12.6%
Dec 16, 4:00:01 PM EST
Earnings Call Transcripts
This Quarter (Q1 '26)
No earnings call transcript available yet
Last Quarter (Q4 '25)
No earnings call transcript available
Key Stats
Market Cap
6.90MP/E (TTM)
-Basic EPS (TTM)
-8.38Dividend Yield
0%Recent Filings
10-Q
Q2 FY2026 results
Astrotech's Q2 FY2026 revenue fell 43% y/y to $148 thousand while gross margin cratered to 5% from 59%, yet operating loss narrowed to $3.9M from $4.3M on 25% R&D cuts and steady SG&A. YTD revenue doubled to $445 thousand with 44% margins, trimming operating loss to $7.4M; diluted EPS of -$4.41 reconciles to 1.7M shares. Cash held at $3.1M with $7.0M short-term investments after $7.5M operating burn offset by investment maturities—no debt, no FCF disclosed in the 10-Q. New Metric Facility lease starts July 2025. Customer concentration persists.
8-K
Q2 revenue dips, R&D falls 25%
Astrotech reported Q2 FY2026 results on February 13, 2026, with revenue at $148 thousand, down from $261 thousand prior year, yet R&D expenses dropped 25% to $1.832 million amid shift to sales for EN-SCAN and Tracer 1000 products. TRACER 1000 now deployed in 35 locations across 16 countries. Cash burn trimmed losses to $3.9 million. New interim CFO and sales director bolster growth push.
8-K
Rights plan extended; directors elected
Astrotech extended its shareholder rights plan to December 20, 2026, via Amendment No. 3 on December 12, 2025, bolstering defenses against takeovers. At the annual meeting that day, stockholders elected six directors amid significant withhold votes and ratified RBSM LLP as auditors for fiscal 2026. Directors approved unanimously by quorum, yet dissent signals governance tension.
10-Q
Q1 FY2026 results
Astrotech jumped revenue to $297 thousand in Q1 FY2026 ended September 30, 2025, up sharply from $34 thousand y/y, fueled by $234 thousand in grant revenue from Phases I/II milestones while U.S. sales hit $256 thousand. Gross margin soared to 63% from 26%, yet operating loss narrowed just 2% to $(3.5M) amid steady SG&A and R&D spend; net loss widened slightly to $(3.5M) or $(2.07) per share from lower other income. Cash burned $3.9M in operations but investing sales lifted short-term investments to $11.3M, leaving $2.6M cash against minimal debt. Revenue hinges on three customers. Cash cushions the burn.
8-K
Q1 revenue jumps 35%
Astrotech reported Q1 FY2026 revenue of $297 thousand, up 35% from Q4 FY2025, driven by 1st Detect's grant revenue and consumables sales; TRACER 1000 now deploys in 34 locations across 16 countries. Cash and equivalents plus liquid investments stood at $13.9 million. Nihanth Badugu joined as COO effective August 13, 2025. Management eyes 2026 sales acceleration.
IPO
Employees
Sector
Industry
A
Agilent Technologies, Inc.
139.19-1.41
AATC
Autoscope Technologies Corporat
6.18-0.01
ALOT
AstroNova, Inc.
7.73-0.26
ASTS
AST SpaceMobile, Inc.
68.37+0.56
ATRO
Astronics Corporation
52.19-0.12
ATXS
Astria Therapeutics, Inc.
12.87-0.05
BRKR
Bruker Corporation
44.96-0.71
MASS
908 Devices Inc.
5.78-0.13
STEC
Santech Holdings Limited
0.96-0.07
TECH
Bio-Techne Corp
57.44-1.25